LaBrosse Nicole Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$2.22M

Insider Activity of LaBrosse Nicole

Biography of LaBrosse Nicole

No biography is available at this moment.

2025-09-22SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF FINANCIAL OFFICER
2,227
0.0019%
$77.95$173,584-10.54%
2025-09-10SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF FINANCIAL OFFICER
20,000
0.0171%
$75.71$1.51M-7.61%
2024-07-22SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF FINANCIAL OFFICER
5,000
0.0039%
$53.93$269,662+3.45%
2024-06-28SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF FINANCIAL OFFICER
10,000
0.0079%
$52.04$520,400+6.68%
2024-06-27SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF FINANCIAL OFFICER
10,000
0.0078%
$51.93$519,340+8.16%
2024-06-26SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF FINANCIAL OFFICER
10,000
0.0078%
$51.82$518,200+7.39%
2023-02-16SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF FINANCIAL OFFICER
2,525
0.0019%
$49.26$124,382-24.87%
2022-11-15SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF FINANCIAL OFFICER
5,000
0.0036%
$53.81$269,053-27.18%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.